This inventor holds 2 USPTO granted patents. Top assignee: The University of Texas System. Active years: 2001-2009.
Company Filing History:
Years Active: 2001-2009
Title: Kirk Lorne Ives: Innovator in Therapeutic Applications
Introduction
Kirk Lorne Ives is a notable inventor based in Dickinson, TX (US). He has made significant contributions to the field of medicine, particularly in the development of therapeutic methods for various conditions. With a total of 2 patents, Ives has focused on innovative solutions that address critical health issues.
Latest Patents
Ives' latest patents include groundbreaking methods for preventing uterine contractions in premature labor or lactation. His invention utilizes thiazolidinedione derivatives, such as troglitazone, to reduce oxytocin-mediated actions. This novel approach offers a therapeutic regimen for treating conditions like preterm labor and labor prior to Caesarian delivery. Additionally, Ives has developed a clinical use of oxytocin and its analogs for treating bone disorders. This invention details the administration of oxytocin to assist in bone remodeling and treat diseases such as osteoporosis and bone fractures.
Career Highlights
Kirk Lorne Ives is affiliated with the University of Texas System, where he continues to advance his research and innovations. His work has the potential to significantly impact the medical field, particularly in obstetrics and orthopedics.
Collaborations
Ives has collaborated with esteemed colleagues, including John A Copland, III and Melvyn Soloff, to further enhance his research and patent developments.
Conclusion
Kirk Lorne Ives exemplifies the spirit of innovation in the medical field through his patents and research. His contributions are paving the way for new therapeutic approaches that can improve patient outcomes.